Business Wire, Author at Digital Health Global

Business Wire

Wired for What’s Next.

Author: Business Wire

Augmedics adds Medtronic AI expert as VP R&D

Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced the appointment of Tal Davidson, MD as Vice President, Research & Development.

AI Health Assistant, Together, Selects Sonde Health to Power its Mental Vitals Tool

Commercial partnership enables users of Together’s app to access enhanced mental health tracking through Sonde’s leading voice technologyBOSTON--(BUSINESS WIRE)--Leading enterprise vocal biomarker company Sonde Health has partnered with Together, an A...

New Report by Parsley Health Pulls Back the Curtain on the State of Health of Women in the Workforce, Reveals Top Concerns – and Opportunities – for Employers

Parsley Health, a digital health company designed to lower costs in patients with complex and chronic conditions using root cause medicine, today announced survey findings that reveal the state of health of women in the workforce in 2023, and the impact on employers.

Massive Bio Pioneers Clinical Trial Recruitment Innovation with Strategic Support from Evernorth Health, Inc.

Massive Bio Inc., a trailblazing entity in the realm of digital health technology, proudly announces a pivotal advancement in clinical trial recruitment, fortified by a strategic relationship with Evernorth Health, Inc (ENI).

Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD

COMISAIR study is now the longest prospective real-world CGM study ever conducted, demonstrating significant and continued HbA1c reduction for patients using real-time CGM over seven years.1 New data shows the Dexcom ONE CGM system delivers a clinic...

“The Future Is Bright” With Opportunities to Grow: BioAlberta’s State of the Industry Reports on Alberta’s Life Sciences and Healthcare Industry

BioAlberta has published its 2023 State of the Industry (SOI) report. This year’s report includes new insights and trends from the industry to reflect market conditions and the growth of the sector. The report’s resu...

Debiopharm Innovation Fund Launches New Seed Funding Activity to Accelerate Digital Transformation of Cancer Care and Pharma R&D

Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, today announced the launch...